Form 4: Richard Ian Griffiths Reports Acquisition of Silence Therapeutics plc Shares

Sentiment:

SEC Form 4


Director Richard Ian Griffiths reports acquiring additional American Depositary Shares (ADS) of Silence Therapeutics plc on April 28 and 29, 2025.

Summary

  • Richard Ian Griffiths, a director of Silence Therapeutics plc, filed a Form 4 detailing changes in beneficial ownership.
  • On April 28, 2025, Griffiths acquired 95,211 American Depositary Shares (ADS) at a price of $3.43 per ADS.
  • On April 29, 2025, Griffiths acquired 54,768 ADS at a price of $3.49 per ADS.
  • Each ADS is immediately convertible into three ordinary shares.
  • Following these transactions, Griffiths directly owns 10,611,278 ordinary shares represented by ADS.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of share acquisitions by a director. The purchases could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

  • The director's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • Shareholders may view the director's increased stake as a positive signal.

Key Dates

DateDescription
04/28/2025Griffiths acquired 95,211 American Depositary Shares at $3.43 each.
04/29/2025Griffiths acquired 54,768 American Depositary Shares at $3.49 each.
04/30/2025Date of signature for the Form 4 filing.

Keywords

Silence Therapeutics plc, Richard Ian Griffiths, Form 4, Beneficial Ownership, American Depositary Shares, ADS, Director, Acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.